National Research Corporation
NRC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $35 | $34 | $34 | $37 |
| % Growth | 1.7% | 1.5% | -9.1% | – |
| Cost of Goods Sold | $15 | $15 | $15 | $14 |
| Gross Profit | $20 | $19 | $19 | $23 |
| % Margin | 57.8% | 56.8% | 56.5% | 61.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $12 | $18 | $10 | $11 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $1 |
| Operating Expenses | $12 | $18 | $10 | $13 |
| Operating Income | $8 | $2 | $9 | $10 |
| % Margin | 22.4% | 4.7% | 25.6% | 26% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | $6 | $1 | $8 | $9 |
| Tax Expense | $2 | $1 | $2 | $2 |
| Net Income | $4 | -$0 | $6 | $7 |
| % Margin | 11.9% | -0.3% | 17.2% | 17.8% |
| EPS | 0.18 | -0.005 | 0.25 | 0.28 |
| % Growth | 3,929.8% | -101.9% | -10.7% | – |
| EPS Diluted | 0.18 | -0.005 | 0.25 | 0.28 |
| Weighted Avg Shares Out | 23 | 23 | 23 | 23 |
| Weighted Avg Shares Out Dil | 23 | 23 | 23 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | $10 | $3 | $10 | $11 |
| % Margin | 28.7% | 9.9% | 30.3% | 30.1% |